…And Then the Medicine for a Rare Childhood Disease Suddenly Became 400 Times More Expensive
Researchers at Erasmus MC discovered that a group of children with a fatal condition benefit from an old drug that costs next to nothing. A Swedish pharmaceutical company obtained the monopoly and is now marketing the drug for an exorbitant amount.
1 Articles
1 Articles
Researchers at Erasmus MC discovered that a group of children with a fatal condition benefit from an old drug that costs next to nothing. A Swedish pharmaceutical company obtained the monopoly and is now marketing the drug for an exorbitant amount.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium